BML-266

Suppliers

Names

[ CAS No. ]:
96969-83-4

[ Name ]:
BML-266

[Synonym ]:
1,4-Bis{[2-(4-hydroxyphenyl)ethyl]amino}-9,10-anthraquinone
9,10-Anthracenedione, 1,4-bis[[2-(4-hydroxyphenyl)ethyl]amino]-
1,4-bis{[2-(4-hydroxyphenyl)ethyl]amino}anthracene-9,10-dione
1,4-bis[(p-hydroxyphenethyl)amino]-anthraquinone
hms3261l04
1,4-di[(4-hydroxyphenethyl)amino]-9,10-dihydroanthracene-9,10-dione

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
780.2±60.0 °C at 760 mmHg

[ Molecular Formula ]:
C30H26N2O4

[ Molecular Weight ]:
478.538

[ Flash Point ]:
425.7±32.9 °C

[ Exact Mass ]:
478.189270

[ PSA ]:
98.66000

[ LogP ]:
4.45

[ Vapour Pressure ]:
0.0±2.8 mmHg at 25°C

[ Index of Refraction ]:
1.733

[ Storage condition ]:
-20°C

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS09

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H400

[ Precautionary Statements ]:
P273

[ Personal Protective Equipment ]:
Eyeshields;Gloves

[ Hazard Codes ]:
N: Dangerous for the environment;

[ Risk Phrases ]:
50/53

[ Safety Phrases ]:
60-61

[ RIDADR ]:
UN 3077 9/PG 3

Articles

An in silico approach to discovering novel inhibitors of human sirtuin type 2.

J. Med. Chem. 47 , 6292-6298, (2004)

Type 2 human sirtuin (SIRT2) is a NAD(+)-dependent cytoplasmic protein that is colocalized with HDAC6 on microtubules. SIRT2 has been shown to deacetylate alpha-tubulin and to control mitotic exit in ...

Discovering inhibitors of human sirtuin type 2: novel structural scaffolds.

J. Med. Chem. 49 , 7239-7241, (2006)

A successful virtual screening experiment of novel SIRT2 inhibitors is described. Four out of 11 experimentally tested compounds showed in vitro inhibitory activity toward SIRT2 in a micromolar level,...


More Articles

Related Compounds

  • BML-259
  • BML 284
  • BML-244
  • BML-190
  • BML-288
  • BML-278
  • 3-({[2-(tert-butoxy)-2-oxoethyl]amino}methyl)-5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2,6-dimethylbenzoic acid
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 3-(But-3-en-2-yl)-1-(3-hydroxybutan-2-yl)thiourea
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • 2,2-Bis((S)-4-(3,5-di-tert-butylphenyl)-4,5-dihydrooxazol-2-yl)acetonitrile